LIFECORE BIOMEDICAL, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- LIFECORE BIOMEDICAL, INC. payments for repurchase of common stock for the quarter ending 2012-05-27 was -$1.00K.
- LIFECORE BIOMEDICAL, INC. payments for repurchase of common stock for the quarter ending 2012-02-26 was $202.00K.
- LIFECORE BIOMEDICAL, INC. payments for repurchase of common stock for the quarter ending 2011-05-29 was $0.00.
- LIFECORE BIOMEDICAL, INC. payments for repurchase of common stock for the quarter ending 2010-08-29 was $362.00K.
- LIFECORE BIOMEDICAL, INC. payments for repurchase of common stock for fiscal 2012 was $5.01M, a 322.80% increase from fiscal 2011.
- LIFECORE BIOMEDICAL, INC. payments for repurchase of common stock for fiscal 2011 was $1.18M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2012-05-27 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $5.01M 10-K · filed 2014-08-01 |
| 2012-02-26 | $202.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | |
| 2011-05-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $1.18M 10-K · filed 2013-08-07 |
| 2010-08-29 | $362.00K 10-Q · filed 2011-10-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |